|Place of Origin:||China|
|Certification:||COA, HPLC MR|
|Model Number:||HBY-Cibinetide ARA 290|
|Minimum Order Quantity:||1KG|
|Packaging Details:||10mg/vial, 10vials/box|
|Delivery Time:||3-5 work days after your payment|
|Payment Terms:||Western Union, T/T, MoneyGram|
|Product Name:||EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment||CAS No:||1208243-50-8|
|Outlook:||White Crystalline Powder||Assay:||99%Min|
|Shelf Life:||2 YEARS||Storage Temperture:||In Cool,dry Place|
HPLC Body Building Peptides,
HPLC EPO Derivative Body Building Peptides,
HPLC Neurological Disease Treatment ara290 peptide
What is EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment?
|Product Name||EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment|
|Deliver Time||Within 24 Hours After Receiving The Payment|
Cibinetide is a first-in-class synthetic peptide designed to activate innate repair mechanisms in the setting of tissue injury as a result of the inflammatory cascade. It selectively binds to the Innate Repair Receptor (IRR) which activates tissue protective, reparative, and anti-inflammatory signaling pathways.
Cibinetide lacks erythropoietic effects as it does not activate EPOR homodimers. Correspondingly, unchanged Hb levels have been reported following repeated applications of cibinetide in patients. Thus, cibinetide is not associated with unintended side effects such as thromboembolism secondary to stimulation of erythropoiesis as ascribed for full length recombinant erythropoietin.
ARA290 is commonly used in clinical trials to treat neurological diseases.
It was proved that ARA290 is good for myocardial infarction, dilated cardiomyopathy, experimental ischemic stroke, peripheral nerve trauma and wound healing.
Package and Shipping of EPO-Derivative Cibinetide ARA 290 For Neurological Disease Treatment